Author

E. W. P. Wong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ChIP-seq· 1 Assay:DNA methylation· 1

Frequent Co-Authors

A. J. Patel· 2 shared C. J. Lee· 2 shared C. R. Antonescu· 2 shared D. Zheng· 2 shared E. Giff· 2 shared J. Yan· 2 shared M. A. Miranda-Roman· 2 shared P. Chi· 2 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. J. Patel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 28, 2022

PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral Mimicry

A. J. Patel, S. Warda, J. L. V. Maag…·P. Chi

This paper identifies synthetic lethality between PRC2 inactivation and DNMT1 inhibition in MPNST, showing enhanced cytotoxicity through retrotransposon activation and innate immune signaling.

DOI 10.1101/2022.05.28.493429

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 27, 2022

Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy

J. Yan, Y. Chen, A. J. Patel…·P. Chi

This study shows that PRC2 inactivation in tumors creates an immune-desert microenvironment, leading to resistance to immunotherapy and suggests strategies to reverse this effect.

DOI 10.1101/2022.05.27.493507

humanDNA methylation

𝕏 PostBluesky